Fitzgerald Meghan 4

What Happened
Meghan Fitzgerald, a director of Tenet Healthcare Corporation (THC), was granted 1,188 restricted stock units (RSUs) on 2026-05-27 (reported on Form 4 filed 2026-05-28). The grant is coded as an award/acquisition (derivative); no cash was paid at grant (acquisition price $0.00). Each RSU is the economic equivalent of one share and will convert to shares (or cash as elected) when they vest.

Key Details

• Transaction date: 2026-05-27; Form 4 filed: 2026-05-28.
• Award: 1,188 restricted stock units (RSUs); acquisition price listed as $0.00.
• Vesting: RSUs vest on the first anniversary of the grant (i.e., 1 year after 2026-05-27).
• Cash election: The reporting person may elect to receive up to 37% of these RSUs in cash in lieu of shares (footnote).
• Shares owned after transaction: Not specified in the provided filing details.
• Timeliness: Filing was submitted the day after the grant date (not marked late).

Context
RSUs are a form of compensation that give the holder the economic equivalent of shares once vested; they are not an immediate purchase or sale and do not necessarily indicate trading sentiment. The grant creates potential future equity (or cash) value tied to Tenet’s stock price at vesting.